4-Bromomethylcoumarins (1a-f) were reacted with 8-hydroxyquinoline to yield quinolinoxymethylcoumarins (2a-f). The structure of all the synthesized compounds were confirmed by spectral studies and screened for their anticancer activities against Dalton's Ascitic lymphoma (DAL) and Ehrlich Ascites Carcinoma (EAC) cell lines. Out of these, compound (2b) (R = 6-OMe) was found to be the most potent cytotoxic compound against DAL and EAC cell lines.
Introduction
A large number of naturally occurring compounds possessed heterocyclic rings as an important part of their structure. Such compounds including indole, quinoline, benzimidazole, coumarins and imidazopyridines are widely used as medicines. Among them, quinoline and its derivatives exhibited remarkable activities such as antimalarial [1] , antiproliferative [2] , photosynthesis-inhibiting [3] , proteasome inhibitors [4] and antioxidative activities [5] . They also act as antifungal [6] , antibacterial [7] , antiprotozoic drugs as well as exhibit antineoplastics [8] and antischistosomal activity [9] .
Compounds containing coumarin rings have remarkable medicinal value due to their potential anticancer [10] , antimicrobial [11] and antiulcerogenic effect [12] properties. They also act as fluorescent probes [13] . In addition, 4-heteroaryloxymethylcoumarins are reported to exhibit significant biological activities such as antibacterial [14] , antifungal [15] , antimicrobial [16] , antidiuretic [17] and anti-inflammatory activity [18] .
On the basis of these literature studies, we set out to synthesize a new series of biologically active compounds containing both of these two important pharmacophores. This study presents the synthesis, characterization and in vitro cytotoxic activities of these new quinolinoxymethylcoumarins [19] (1a-f) were synthesized by the Pechmann cyclisation of phenols with 4-bromoethylacetoacetate [20] .
Chemistry

4-Bromomethylcoumarins
6-Methyl-4-bromomethylcoumarin reacted with 8-hydroxyquinoline in the presence of anhydrous K2CO3 to give 6-methyl-4-(quinolin-8-yloxymethyl)-chromone-2-one [21] . We have extended the same method to other substituent of 4-bromomethylcoumarins (1a-f) (Scheme 1). 
Results and Discussion
In vitro anticancer screening
The newly synthesized compounds were evaluated for their in vitro cytotoxic activity against Dalton's Lymphoma Ascites (DAL) and Ehrlich Ascites Carcinoma (EAC) Cells using Dhamija method [22] . 5-Fluorouracil which is one of the most effective anticancer agents was used as the reference drug in this study.
The relationship between surviving fraction and drug concentration was plotted to obtain the survival curve of Dalton's Lymphoma Ascites (DAL) and Ehrlich Ascites Carcinoma (EAC) cells. The response parameter calculated was the IC50 value, which corresponds to the concentration required for 50% inhibition of cell viability. The IC50 of the synthesized compounds compared to the reference drug are shown in Table 1 and the results are represented graphically in Figure 1 .
The investigation of in vitro cell cytotoxicity (Table 1 ) against DAL cell revealed that the most of the tested compounds exhibited good activity. The Compound (2b) (R = 6-OCH3) was found to be the most potent against DAL cell with IC50 value of 50.76 µg/mL. The compound (2e) (R= 6-Br) was found to be highly active against DAL cell with IC50 value of 65.87 µg/mL. The compounds (2a) (R= 7-CH3), (2c) (R= 5,6-Benzo) and (2d) (R= 6-Cl) showed moderate activity against DAL cell with IC50 between 78.01 and 84.54 µg/mL.
The compound (2f) (R= 6-F) showed poor activity against DAL cell with IC50 104.25 µg/mL.
The investigation of in vitro cell cytotoxicity (Table-1 ) against EAC cell revealed that the most of the tested compounds exhibited good activity. The Compound (2b) (R = 6-OCH3) was the most potent compound in this screening against EAC cell with IC50 value of 41.25 µg/mL. The compounds (2d) (R = 6-Cl) and (2f) (R = 6-F) were found to be highly active against EAC cell with IC50 value between 69.96 and 56.41 µg/mL. The compounds (2a) (R = 7-CH3), (2c) (R = 5,6-Benzo) and (2e) (R = 6-Br) showed poor activity against EAC cell with IC50 between 104.67 and 115.23 µg/mL. 
Experimental section
General
The melting points were determined by open capillary method using electric melting point apparatus and are uncorrected. The IR spectra (KBr disc) were recorded on a Shimadzu-8400S FT-IR Spectrophotometer. 1 H NMR and 13 C NMR were recorded on Bruker 400 MHz spectrometer by using CDCl3 as a solvent and TMS as an internal standard. The chemical shifts are expressed in δ ppm. The purity of the compound was checked by TLC.
General procedure for the synthesis of 4-(quinolin-8-yloxymethyl)-chromone-2-one (2a-f).
8-Hydroxyquinoline (0.493g, 3.4 mmol) and anhydrous K2CO3 (1.38g, 10 mmol) were stirred in 25 ml of dry acetone for 30 min.
One of the 4-bromomethylcoumarins 1(a-f) (3.4 mmol) was added and stirring was continued for 24 h. The reaction mixture was concentrated to one fourth volume and poured on to crushed ice. The solid separated was filtered and washed with 10 ml of 5% HCl. Then, it was washed with 50 ml of cold water. The crude product was dried and recrystallised from ethanol. 
Conclusion
The methoxy substitution at 6-position of coumarin moiety was found to enhance the in vitro cytotoxicity against both DAL and EAC cell lines.
